BR9714269A - Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos - Google Patents
Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicosInfo
- Publication number
- BR9714269A BR9714269A BR9714269-7A BR9714269A BR9714269A BR 9714269 A BR9714269 A BR 9714269A BR 9714269 A BR9714269 A BR 9714269A BR 9714269 A BR9714269 A BR 9714269A
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- compound
- preparation
- pharmaceutical composition
- bacterial infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA CONTROLAR UMA INFECçãO BACTERIANA EM UM MAMìFERO E PARA A PREPARAçãO DE COMPOSTOS MACRóLIDOS TRICìCLICOS". Compostos ou seus sais ou ésteres farmaceuticamente aceitáveis, das fórmulas (I) ou (IV) em que A,B,D eE, R^ 1^, R^ 2^ e Z especificamente definidos, tendo atividade antibacteriana, composições farmacêuticas contendo os ditos compostos, tratamento de infecções bacterianas com tais composições e processos para preparação dos compostos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/779,786 US6274715B1 (en) | 1995-11-08 | 1997-01-07 | Tricyclic erythromycin derivatives |
PCT/US1997/005871 WO1998030574A1 (en) | 1997-01-07 | 1997-04-07 | Tricyclic erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9714269A true BR9714269A (pt) | 2000-04-18 |
Family
ID=25117567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9714269-7A BR9714269A (pt) | 1997-01-07 | 1997-04-07 | Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos |
Country Status (15)
Country | Link |
---|---|
US (1) | US6274715B1 (pt) |
EP (1) | EP0961776A1 (pt) |
JP (1) | JP2001507714A (pt) |
KR (1) | KR20000069935A (pt) |
CN (1) | CN1244202A (pt) |
AR (1) | AR006678A1 (pt) |
AU (1) | AU2449597A (pt) |
BR (1) | BR9714269A (pt) |
CA (1) | CA2277116A1 (pt) |
CZ (1) | CZ231599A3 (pt) |
HU (1) | HUP0001518A3 (pt) |
IL (1) | IL130328A0 (pt) |
NZ (1) | NZ336174A (pt) |
TW (1) | TW442490B (pt) |
WO (1) | WO1998030574A1 (pt) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE296832T1 (de) * | 1996-09-04 | 2005-06-15 | Abbott Lab | 6-o-substituierte ketoliden mit antibakteriellen wirkung |
FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
FR2784682B1 (fr) * | 1998-10-15 | 2002-12-06 | Hoechst Marion Roussel Inc | Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments |
US6514944B2 (en) * | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US6395710B1 (en) | 1999-04-16 | 2002-05-28 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
WO2000071557A1 (en) * | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
US6569836B2 (en) | 1999-12-02 | 2003-05-27 | Abbott Laboratories | 6-O-alkyl-2-nor-2-substituted ketolide derivatives |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
PL214669B1 (pl) | 2001-06-20 | 2013-08-30 | Daiichi Sankyo Company | Pochodne diaminy, kompozycja je zawierajaca oraz ich zastosowanie |
EP1415992B1 (en) | 2001-08-09 | 2012-05-02 | Daiichi Sankyo Company, Limited | Diamine derivatives |
US20040014690A1 (en) * | 2002-02-13 | 2004-01-22 | Zhenkun Ma | Macrolides with activity against methicillin-resistant staphylococcus aureus |
US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
US6841664B2 (en) * | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
WO2003102010A1 (en) * | 2002-05-31 | 2003-12-11 | Janssen Pharmaceutica N.V. | 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
US6750204B2 (en) | 2002-06-25 | 2004-06-15 | Enanta Pharmaceuticals, Inc. | 11-C-substituted ketolides |
US6812216B2 (en) | 2002-06-25 | 2004-11-02 | Enanta Pharmaceuticals, Inc. | 11-C-substituted derivatives of clarithromycin |
AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
JP2006523229A (ja) * | 2003-03-05 | 2006-10-12 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | 二官能性複素環式化合物ならびにその製造および使用方法 |
US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
EP1682563A1 (en) * | 2003-10-30 | 2006-07-26 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same |
WO2005049632A1 (en) * | 2003-11-18 | 2005-06-02 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
US6953782B2 (en) | 2003-12-24 | 2005-10-11 | Enanta Pharmaceuticals, Inc. | 11-C-substituted erythromycin derivatives |
WO2005067564A2 (en) * | 2004-01-07 | 2005-07-28 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic erythromycin derivatives |
US7265094B2 (en) * | 2004-01-09 | 2007-09-04 | Enanta Pharmaceuticals, Inc. | 9N-substituted 6-11 bicyclic erythromycin derivatives |
US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
EP2716647A3 (en) * | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
WO2006065743A2 (en) * | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | Tetracylic bicyclolides |
US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
US20060252710A1 (en) * | 2005-05-04 | 2006-11-09 | Guoqiang Wang | 6-11 Bridged oxime erythromycin derivatives |
US8273720B2 (en) * | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
US8354383B2 (en) * | 2007-09-17 | 2013-01-15 | Enanta Pharmaceuticals, Inc. | 6,11-bridged biaryl macrolides |
NZ600635A (en) * | 2007-09-17 | 2013-06-28 | Enanta Pharm Inc | 6, 11-bridged biaryl macrolides |
AU2008316830B2 (en) * | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
US8208698B2 (en) * | 2007-12-14 | 2012-06-26 | Mela Sciences, Inc. | Characterizing a texture of an image |
TW200946109A (en) * | 2008-05-09 | 2009-11-16 | Enanta Pharm Inc | Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides |
DK2358379T3 (en) | 2008-10-24 | 2016-03-07 | Cempra Pharmaceuticals Inc | BIOFORSVAR USING TRIAZOLHOLDIGE macrolides |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
AU2010292010B2 (en) | 2009-09-10 | 2016-01-07 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
US20110064287A1 (en) * | 2009-09-14 | 2011-03-17 | Alexandru Bogdan | Characterizing a texture of an image |
KR101831685B1 (ko) * | 2010-01-25 | 2018-02-23 | 롬 앤드 하스 일렉트로닉 머트어리얼즈 엘엘씨 | 질소-함유 화합물을 포함하는 포토레지스트 |
CA2793884C (en) | 2010-03-22 | 2019-09-10 | Cempra Pharmaceuticals, Inc. | Crystalline forms of a macrolide, and uses therefor |
DK2571506T3 (en) | 2010-05-20 | 2017-08-28 | Cempra Pharmaceuticals Inc | PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES |
EP2613630A4 (en) | 2010-09-10 | 2014-01-15 | Cempra Pharmaceuticals Inc | FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES |
WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
US9861616B2 (en) | 2013-03-14 | 2018-01-09 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
CN104650166B (zh) * | 2014-11-17 | 2017-12-05 | 广东东阳光药业有限公司 | 一种大环内酯的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69127457T2 (de) | 1990-11-28 | 1998-01-22 | Taisho Pharmaceutical Co Ltd | 6-0-methylerythromycin a-derivat |
US5523399A (en) | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
DK0638585T3 (da) * | 1992-04-22 | 1996-12-02 | Taisho Pharmaceutical Co Ltd | 5-O-desosaminylerythronolid-A-derivater |
JP3227871B2 (ja) * | 1993-02-25 | 2001-11-12 | 大正製薬株式会社 | 6−o−メチルエリスロマイシンa誘導体 |
WO1997017356A1 (en) | 1995-11-08 | 1997-05-15 | Abbott Laboratories | Tricyclic erythromycin derivatives |
-
1997
- 1997-01-07 US US08/779,786 patent/US6274715B1/en not_active Expired - Lifetime
- 1997-04-07 BR BR9714269-7A patent/BR9714269A/pt not_active IP Right Cessation
- 1997-04-07 NZ NZ336174A patent/NZ336174A/en unknown
- 1997-04-07 CA CA002277116A patent/CA2277116A1/en not_active Abandoned
- 1997-04-07 WO PCT/US1997/005871 patent/WO1998030574A1/en not_active Application Discontinuation
- 1997-04-07 AU AU24495/97A patent/AU2449597A/en not_active Abandoned
- 1997-04-07 HU HU0001518A patent/HUP0001518A3/hu unknown
- 1997-04-07 CZ CZ992315A patent/CZ231599A3/cs unknown
- 1997-04-07 IL IL13032897A patent/IL130328A0/xx unknown
- 1997-04-07 KR KR1019997006148A patent/KR20000069935A/ko not_active Application Discontinuation
- 1997-04-07 JP JP53082898A patent/JP2001507714A/ja not_active Ceased
- 1997-04-07 CN CN97181288A patent/CN1244202A/zh active Pending
- 1997-04-07 EP EP97920261A patent/EP0961776A1/en not_active Withdrawn
- 1997-04-14 TW TW086104775A patent/TW442490B/zh not_active IP Right Cessation
- 1997-04-16 AR ARP970101538A patent/AR006678A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1244202A (zh) | 2000-02-09 |
AR006678A1 (es) | 1999-09-08 |
EP0961776A1 (en) | 1999-12-08 |
NZ336174A (en) | 2001-02-23 |
HUP0001518A2 (hu) | 2000-09-28 |
IL130328A0 (en) | 2000-06-01 |
KR20000069935A (ko) | 2000-11-25 |
TW442490B (en) | 2001-06-23 |
US6274715B1 (en) | 2001-08-14 |
WO1998030574A1 (en) | 1998-07-16 |
CA2277116A1 (en) | 1998-07-16 |
CZ231599A3 (cs) | 1999-12-15 |
HUP0001518A3 (en) | 2001-11-28 |
JP2001507714A (ja) | 2001-06-12 |
AU2449597A (en) | 1998-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9714269A (pt) | Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos | |
BR9714287A (pt) | Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero. | |
TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
BRPI9810519B8 (pt) | derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos. | |
BR0116216A (pt) | Inibidores de girase e seus usos | |
PT876388E (pt) | Derivados de eritromicina triciclica | |
BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
BR9510423A (pt) | Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana | |
BR9812577A (pt) | Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas | |
BR9611400A (pt) | "agentes antimicobiano de benzoxazina". | |
BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
BRPI9915480B8 (pt) | azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos. | |
BR9708930A (pt) | Composto derivado de 3-descladinose-2,3-anidro-eritromicina ou um seu sal ou éster farmaceuticamente aceitável processo para a preparação do composto composição farmacêutica e processo de tratamento de infecções bacterianas | |
BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
BR9908522A (pt) | Composto, pró-droga, intermediário para a preparação de um composto, composição farmacêutica, processos para tratar e prevenir infecção por pneumovìrus, para tratar células em cultura, para tratar materiais biológicos, e, para preparar um composto | |
ATE68501T1 (de) | Antibakterielle zusammensetzung. | |
BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
BR9804769A (pt) | Processo para tratar ou prevenir infecção por pestivìrus em um hospedeiro mamìfero tendo ou sendo suscetìvel a referida infecção,e , para tratar c~elulas de mamìferos em cultura, e, em mamìferos biológicos | |
NO880811L (no) | Krystalliserte cefam-syreaddisjonssalter og fremgangsmaatetil deres fremstilling. | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR9807444A (pt) | Produto antimicrobial | |
BR9809489A (pt) | Composto, processo para preparar o mesmo, e, composição farmacêutica e processo para tratar infecções bacterianas. | |
DE3775823D1 (de) | Pharmazeutische zubereitung zur behandlung bakterieller infektionen. | |
IL83626A0 (en) | New macrolide antibiotic,a microbiological process for its preparation,and pharmaceutical compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A,8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1833 DE 21/02/2006. |
|
B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C07H 17/00; C07H 17/08; A61K 31/71. Ipc: C07H 17/08 (2006.01), C07H 17/00 (2006.01) Ipc: C07H 17/08 (2006.01), C07H 17/00 (2006.01) |